17α-Bromoprogesterone (17α-BP) is a progestin which was first described in 1957 and was never marketed.[1][2][3][4] It is about twice as potent as progesterone in terms of progestogenic activity in animal bioassays.[1] 17α-BP is a parent compound of haloprogesterone (6α-fluoro-17α-bromoprogesterone) and 6α-methyl-17α-bromoprogesterone.[5]

See also

References

  1. ^ a b Engel CR, Jahnke H (November 1957). "Steroids and related products. X. 17 alpha-Bromoprogesterone, a new potent gestogen". Canadian Journal of Biochemistry and Physiology. 35 (11): 1047–1055. doi:10.1139/o57-120. PMID 13479803.
  2. ^ Seeley DH, Wang WY, Salhanick HA (November 1982). "Molecular interactions of progesterone analogues with rabbit uterine cytoplasmic receptor". The Journal of Biological Chemistry. 257 (22): 13359–13366. doi:10.1016/S0021-9258(18)33456-2. PMID 7142152.
  3. ^ Bohl M, Simon Z, Vlad A, Kaufmann G, Ponsold K (1987). "MTD calculations on quantitative structure-activity relationships of steroids binding to the progesterone receptor". Zeitschrift für Naturforschung C. 42 (7–8): 935–940. doi:10.1515/znc-1987-7-834. PMID 2961153. S2CID 22962904.
  4. ^ Simon Z, Bohl M (1992). "Structure-activity Relations in Gestagenic Steroids by the MTD Method. The Case of Hard Molecules and Soft Receptors". Quantitative Structure-Activity Relationships. 11 (1): 23–28. doi:10.1002/qsar.19920110104. ISSN 0931-8771.
  5. ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 179, 620. ISBN 978-1-4757-2085-3.
Allikas: https://en.wikipedia.org/wiki/17%CE%B1-Bromoprogesterone
No tags for this post.